Significant biosimilar activities this week include:

  • 24 Aug 20, JP: Merck announced Keytruda® (pembrolizumab) has received two additional approvals from the Japanese Pharmaceuticals and Medical Devices Agency:

    • new indication for the treatment of patient...

Significant biosimilar activities this week include:
 

  • June 28 US: Genentech filed a complaint against Samsung Bioepis in the District Court of Delaware under the BPCIA, alleging infringement of 14 patents related to SB8 (Samsung's proposed bevacizumab biosimil...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags